Physical Activity as Self-Management Approach to Improve Health Outcomes in AML

Virginia Commonwealth University (VCU)

Status: Completed

Conditions: Monocytic; Myeloid; Leukemia

Treatments: Behavioral: BSMA

Study type: Interventional

Funder types: Other

Identifiers

NCT02584296

HM20004012

MCC-15-11061

Details and patient eligibility

About

Physical Activity as a Self-Management Approach to Improve Health Outcomes in Acute Myeloid Leukemia

Full description

Guided by the information-motivation-behavioral skills model and using a quasi-experimental cohort control research design, the primary aim of this study is to: Determine the feasibility of the biobehavioral self management approach (BSMA) program involving physical activity (PA) in patients receiving consolidation treatment for AML. The primary feasibility outcomes for this aim will be rates of recruitment, refusal, retention and attrition; in addition investigators will test methods and procedures of the prescribed BSMA PA program, including assessing adherence, participant acceptance and perceived benefit.

Enrollment: 23 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥18 years
• diagnosis of AML
• hospitalized for consolidation chemotherapy within 1 day (+/- 2 days)
• read and write in English
• able to stand independently
• not experiencing psychiatric neurological disorders (assessed through clinical team members) that would prevent obtaining consent.

Exclusion criteria

• currently experiencing psychiatric or neurologic disorders that would prevent their ability to provide consent.

Trial design

23 participants in 2 patient groups

Usual care control

No Intervention group

Description:

Phase 1 will be observation only, and will be considered a usual care control group, activity at home.

Biobehavioral self management approach

Experimental group

Description:

Phase 2 participants will receive the Biobehavioral self management approach (BSMA) intervention aligned with the IMB model; introduced over three days of each five-day consolidation chemotherapy hospital admission.

Treatment:

Behavioral: BSMA